Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 525 of 2026 entries
View as:

An Observational Study of Peginterferon Alfa-2a (PEGASYS®) in Patients With HBeAg Positive or HBeAg Negative Chronic Hepatitis B

Phase: N/A Priority: Normal
NCT ID: NCT01667432 Org: User:
Start: 07/08/11 End: 08/12/14 Due: 08/12/15

A Study of Avastin (Bevacizumab) in Combination With Carboplatin-Based Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT00700180 Org: User:
Start: 09/30/08 End: 09/30/12 Due: 09/30/13

An Observational Study of Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) in Stage V Chronic Kidney Disease Participants on Hemodialysis

Phase: N/A Priority: Normal
NCT ID: NCT01940484 Org: User:
Start: 08/31/09 End: 07/31/12 Due: 07/31/13

Study in Participants With Early-Stage or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive Breast Cancer to Evaluate Treatment With Trastuzumab Plus (+) Pertuzumab + Docetaxel Compared With Trastuzumab + Placebo + Docetaxel

Phase: N/A Priority: Normal
NCT ID: NCT02586025 Org: User:
Start: 03/14/16 End: 03/14/22 Due: 03/14/23

A Study of Atezolizumab Versus Observation as Adjuvant Therapy in Participants With High-Risk Muscle-Invasive Urothelial Carcinoma (UC) After Surgical Resection

Phase: N/A Priority: Normal
NCT ID: NCT02450331 Org: User:
Start: 10/05/15 End: 06/14/22 Due: 06/14/23

A Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab as Adjunct Treatment in Prevention of Vaso-Occlusive Episodes (VOE) in Sickle Cell Disease (SCD)

Phase: N/A Priority: Normal
NCT ID: NCT05075824 Org: User:
Start: 03/09/22 End: 04/08/26 Due: 04/08/27

A Study of RO5429083 in Patients With Metastatic and/or Locally Advanced, CD44-Expressing, Malignant Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01358903 Org: User:
Start: 06/30/11 End: 03/31/14 Due: 03/31/15

Efficacy, Safety, and Tolerability Study of Pirfenidone in Combination With Sildenafil in Participants With Advanced Idiopathic Pulmonary Fibrosis (IPF) and Intermediate or High Probability of Group 3 Pulmonary Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT02951429 Org: User:
Start: 12/31/16 End: 08/22/20 Due: 08/22/21

Observational Study of Methoxy Polyethylene Glycol Epoetin Beta Daily Use in Participants on Peritoneal Dialysis

Phase: N/A Priority: Normal
NCT ID: NCT02596945 Org: User:
Start: 07/31/09 End: 02/28/11 Due: 02/28/12

BONDIR Study: A Study of Intravenous Bonviva (Ibandronate) After Recent Vertebral Osteoporotic Fracture in Patients With Osteoporosis.

Phase: N/A Priority: Normal
NCT ID: NCT00493623 Org: User:
Start: 06/30/07 End: 12/31/09 Due: 12/31/10

A Study of NeoRecormon (Epoetin Beta) in Anemic Patients With Chronic Hepatitis C.

Phase: N/A Priority: Normal
NCT ID: NCT00560274 Org: User:
Start: 03/31/08 End: 11/30/11 Due: 11/30/12

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of RO7062931 in Healthy Chinese Volunteers.

Phase: N/A Priority: Normal
NCT ID: NCT03505190 Org: User:
Start: 05/03/18 End: 07/05/19 Due: 07/05/20

A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)

Phase: N/A Priority: Normal
NCT ID: NCT00422383 Org: User:
Start: 02/28/06 End: 03/31/13 Due: 03/31/14

Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

Phase: N/A Priority: Normal
NCT ID: NCT00118742 Org: User:
Start: 08/31/05 End: 12/31/08 Due: 12/31/09

A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C Infection (CHC).

Phase: N/A Priority: Normal
NCT ID: NCT00077649 Org: User:
Start: 01/31/04 End: 12/31/05 Due: 12/31/06

A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Subtudy to Evaluate the Safety of Re-Implanting the PDS With Ranibizumab in Participants With DME

Phase: N/A Priority: Normal
NCT ID: NCT04108156 Org: User:
Start: 09/30/19 End: 11/16/26 Due: 11/16/27

Comparative Bioavailability Study of Film-coated Tablet and Granule Formulations of RG1662

Phase: N/A Priority: Normal
NCT ID: NCT02194244 Org: User:
Start: 08/31/14 End: 08/31/14 Due: 08/31/15

A Pharmacokinetics Study to Investigate the Effect of Ketoconazole on Vemurafenib in Patients With BRAFV600 Mutation-Positive Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT01765556 Org: User:
Start: 10/31/13 End: 10/31/13 Due: 10/31/14

A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Levels and Participant Satisfaction in Participants With Multiple Sclerosis (MS)

Phase: N/A Priority: Normal
NCT ID: NCT06780150 Org: User:
Start: 09/26/24 End: 11/30/26 Due: 11/30/27

ANNAPURNA: A Study of The Combination of RO5466731, RO5190591, Ritonavir and Copegus (Ribavirin) With or Without RO5024048 in Patients With Chronic Hepatitis C Who Are Either Treatment-Naïve or Have Previously Experienced a Null Response to Interferon-Based Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01628094 Org: User:
Start: 06/30/12 End: 11/30/13 Due: 11/30/14

A Study of The Excretion Balance, Pharmacokinetics and Metabolism of A Single Oral Dose of [14C]-Labeled RO4917523 in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01592890 Org: User:
Start: 04/30/12 End: 05/31/12 Due: 05/31/13

A Study of MabThera (Rituximab) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia.

Phase: N/A Priority: Normal
NCT ID: NCT00738374 Org: User:
Start: 11/03/08 End: 01/14/13 Due: 01/14/14

An Observational Study of Mircera (Methoxy Polyethylene Glycol-epoetin Beta) in Patients With Chronic Kidney Disease Not On Dialysis

Phase: N/A Priority: Normal
NCT ID: NCT01318512 Org: User:
Start: 07/31/10 End: 12/31/13 Due: 12/31/14

Study to Determine Optimum Intravenous Starting Dose of MIRCERA for Treatment of Pediatric Participants With Anemia and Chronic Kidney Disease on Hemodialysis

Phase: N/A Priority: Normal
NCT ID: NCT00717366 Org: User:
Start: 07/31/08 End: 03/31/16 Due: 03/31/17

A Study of Tarceva (Erlotinib) and Avastin (Bevacizumab) in Patients With Advanced or Metastatic Liver Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT00605722 Org: User:
Start: 03/31/08 End: 09/30/10 Due: 09/30/11